During the past decade, MHAT Dr Stefan Cherkezov conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 9 clinical trials were completed, i.e. on average, 56.3% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 5 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "MHAT Dr Stefan Cherkezov" #1 sponsor was "Janssen Research & Development, LLC" with 4 trials, followed by "Bayer" with 3 trials sponsored, "Galapagos NV" with 3 trials sponsored, "Pfizer" with 3 trials sponsored and "Boehringer Ingelheim" with 3 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "MHAT Dr Stefan Cherkezov" #1 collaborator was "Gilead Sciences" with 3 trials as a collaborator, "OCT Clinical Trials" with 2 trials as a collaborator, "Department of Health and Human Services" with 1 trials as a collaborator, "IQVIA Pvt. Ltd" with 1 trials as a collaborator and "Quintiles, Inc." with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "MHAT Dr Stefan Cherkezov" are "Arthritis, Rheumatoid" (3 trials), "COVID-19" (2 trials), "Crohn's Disease" (2 trials), "Heart Failure" (2 trials) and "Influenza A" (2 trials). Many other conditions were trialed in "MHAT Dr Stefan Cherkezov" in a lesser frequency.

Most popular intervention types in "MHAT Dr Stefan Cherkezov" are "Drug" (18 trials) and "Other" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (10 trials), "Filgotinib" (3 trials), "BI 695501" (2 trials), "PF-07321332" (2 trials) and "Pimodivir 600 mg" (2 trials). Other intervention names were less common.

The vast majority of trials in "MHAT Dr Stefan Cherkezov" are 18 trials for "All" genders.

Currently, there are NaN active trials in "MHAT Dr Stefan Cherkezov". undefined are not yet recruiting, 1 are recruiting, 3 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 9 completed trials in MHAT Dr Stefan Cherkezov, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in MHAT Dr Stefan Cherkezov, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 15 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".